The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

In a retrospective study of the algorithm, McGill researchers used it to analyze blood sugar readings and insulin dosing data collected from 20 users of the Bigfoot Unity system, and found that the ...

Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year. It requires careful calculations of insulin needs and bothersome daily ...

Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar. This occurs in roughly one-quarter to one-half of these patients and can lead to serious ...

Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be ...

MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...

An algorithm paired with a continuous glucose monitor can help people living with type 2 diabetes better manage their condition by recommending insulin-dose adjustments. This is the claim of ...

To address this, researchers created a self-adjusting subcutaneous insulin algorithm (SQIA) for use at UCSF’s San Francisco hospitals. A new study shows that their SQIA reduces rates of severe ...

PALO ALTO, Calif., April 11, 2023 /PRNewswire/ -- Glooko, Inc., announced today a new Global partnership with Hedia, integrating its technology into Glooko's diabetes management platforms for ...

Control of blood glucose levels in patients with type 2 diabetes decreases the risk of complications; nevertheless, this goal can be difficult to achieve. The introduction of BASAL INSULIN ANALOGUES, ...